Naruhiko Ishiwada (N Ishiwada)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Cerebrospinal Fluid

Respiratory Syncytial Virus

Top Venues

Infectious diseases and therapy

Access microbiology

Epidemiology and infection

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy 13 (7) (2024)
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy 13 (7) (2024)
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy (2024)
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy 13 (7) (2024)
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy 13 (7) (2024)
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W Law, Kazumasa Kamei
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan. Infectious diseases and therapy 13 (7) (2024)
Misako Ohkusu, Kenichi Takeshita, Noriko Takeuchi, Naruhiko Ishiwada
Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan. Access microbiology 5 (3) (2023)
Misako Ohkusu, Kenichi Takeshita, Noriko Takeuchi, Naruhiko Ishiwada
Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan. Access microbiology 5 (3) (2023)
Jun Kobayashi, Misako Ohkusu, Takehisa Matsumoto, Noriko Kubota, Naruhiko Ishiwada
Bacteriological and molecular characterization of temperature- and CO 2 -dependent Streptococcus pneumoniae serotype 24F ST162 isolated from Japanese children. Microbiology spectrum (2023)
Misako Ohkusu, Kenichi Takeshita, Noriko Takeuchi, Naruhiko Ishiwada
Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan. Access microbiology 5 (3) (2023)
Misako Ohkusu, Kenichi Takeshita, Noriko Takeuchi, Naruhiko Ishiwada
Increase in prevalence of Streptococcus pneumoniae serogroup 24 in children upon introducing 13-valent pneumococcal conjugate vaccine in Japan. Access microbiology 5 (3) (2023)
Noriko Takeuchi, Bin Chang, Kenichi Takeshita, Sachiko Naito, Yoshiko Takahashi, Haruka Hishiki, Naruhiko Ishiwada
Epidemiology and bacterial characteristics of invasive group B streptococcus disease: a population-based study in Japan in 2010-2020. Epidemiology and infection 150 (2022)
Kenichi Takeshita, Noriko Takeuchi, Misako Ohkusu, Haruka Hishiki, Yuki Shiko, Yohei Kawasaki, Bin Chang, Naruhiko Ishiwada
Epidemiological characteristics in serotype 24 paediatric invasive pneumococcal disease according to an 11-year population-based study in Japan. Epidemiology and infection 150 (2022)
N Takeuchi, S Naito, M Ohkusu, K Abe, K Shizuno, Y Takahashi, Y Omata, T Nakazawa, K Takeshita, H Hishiki, T Hoshino, Y Sato, Naruhiko Ishiwada
Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan. Epidemiology and infection 148 (2020)